[HTML][HTML] Advances in Antioxidant Applications for Combating 131I Side Effects in Thyroid Cancer Treatment
L Yang, J Ma, P Lei, J Yi, Y Ma, Z Huang, T Wang… - Toxics, 2023 - mdpi.com
Thyroid cancer is the most common endocrine cancer, and its prevalence has been
increasing for decades. Approx. 95% of differentiated thyroid carcinomas are treated using …
increasing for decades. Approx. 95% of differentiated thyroid carcinomas are treated using …
[HTML][HTML] Feasibility of apatinib in radioiodine-refractory differentiated thyroid carcinoma
W Du, X Shi, Q Fang, X Zhang, S Liu - Frontiers in Endocrinology, 2022 - frontiersin.org
Objectives Our aim was to describe our experience in using apatinib as treatment for
radioiodine-refractory differentiated thyroid carcinoma (RAIR-DTC). Methods Forty-seven …
radioiodine-refractory differentiated thyroid carcinoma (RAIR-DTC). Methods Forty-seven …
Assessing potential impact of 2015 American Thyroid Association guidelines on community standard practice for I-131 treatment of low-risk differentiated thyroid …
Abstract Objectives The 2015 American Thyroid Association (ATA) guidelines called for
significantly more selective 131 I therapy in patients with low-risk differentiated thyroid …
significantly more selective 131 I therapy in patients with low-risk differentiated thyroid …
Diagnosing postoperative lymph node metastasis in thyroid cancer with multimodal radiomics and clinical features
X Fan, H Zhang, Z Wang, X Zhang, S Qin… - Digital …, 2024 - journals.sagepub.com
Purpose This study aims to evaluate the diagnostic value of texture analysis for lymph node
metastasis after thyroid cancer surgery. Methods We retrospectively analyzed patients who …
metastasis after thyroid cancer surgery. Methods We retrospectively analyzed patients who …
Impact factors of benefiting from initial 131I ablation in patients with intermediate-risk differentiated thyroid carcinoma: a study based on a re-evaluation of therapeutic …
L Ren, Y Hu, Y Hu, D Xiao, J Sun, B Zhu… - Nuclear Medicine …, 2024 - journals.lww.com
Objective This study was carried out to confirm whether patients with intermediate-risk
differentiated thyroid cancer (DTC) could benefit from initial 131 I ablation and to identify the …
differentiated thyroid cancer (DTC) could benefit from initial 131 I ablation and to identify the …
[HTML][HTML] Aspects Considered in Differentiated Thyroid Cancer for Radioiodine Therapy
A Elliyanti - Thyroid Cancer-The Road From Genes to Successful …, 2022 - intechopen.com
Thyroid cancer incidence has rapidly increased in high-income countries for the past 30
years. The increase in thyroid cancer cases may be due to improved diagnostic methods or …
years. The increase in thyroid cancer cases may be due to improved diagnostic methods or …
Оценка эффективности радиойодабляции при дифференцированном раке щитовидной железы
АЮ Шуринов, ВВ Крылов… - Онкологический …, 2023 - oncoradjournal.ru
Аннотация На территории России значительно возросла заболеваемость раком
щитовидной железы после аварии на Чернобыльской АЭС 1986 г., и в настоящее …
щитовидной железы после аварии на Чернобыльской АЭС 1986 г., и в настоящее …
Sinteza i karakterizacija radiofarmaceutika na bazi superparamagnetnih nanočestica i efekat dualne terapije na eksperimentalnom modelu adenokarcinoma kolona
A Stanković - 2021 - search.proquest.com
Radionuklidna terapija (RT) predstavlja selektivnu isporuku zračenja tumorskom tkivu,
primjenom jednog ili više radioizotopa (α, β, Ožeov elektron emitera) u sastavu …
primjenom jednog ili više radioizotopa (α, β, Ožeov elektron emitera) u sastavu …
[PDF][PDF] Les carcinomes papillaires de la glande thyroïde: Expérience du service ORL de l'HMA
MO MOUSTAHFID - 1996 - wd.fmpm.uca.ma
Les carcinomes papillaires de la glande thyroïde : Expérience du service ORL de l’HMA
Page 1 Année 2022 Thèse N321 Les carcinomes papillaires de la glande thyroïde …
Page 1 Année 2022 Thèse N321 Les carcinomes papillaires de la glande thyroïde …